Chl02 0005 01
Chlorothiazide Sodium
Product Images NDC 17478-419
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Chlorothiazide Sodium (NDC 17478-419). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chl02 0005 02
Chl02 0005 03
Chlorothiazide Sodium for Injection, USP is a sterile, lyophilized powder used to prepare intravenous solutions. Each single-dose vial contains 500mg of chlorothiazide, with inactives including 250mg Mannitol and Sodium Hydroxide. To reconstitute, it should be mixed with a minimum of 18mL of sterile water for injection, and the resulting isotonic solution should be used immediately for single-dose only. The recommended dosage for adults is between 500mg to 1g daily, and any excess solution should be discarded. The product should be stored at 20° to ? 25°C (68°t0 77°F) and more information on dosages, and storage can be found on the package insert.*
Chl02 0005 04
This is a description of Chlorothiazide, an intravenous solution used to treat conditions such as high blood pressure and edema. The text provides instructions for reconstituting the solution and dosage information, as well as storage instructions. It also includes the active ingredient, Cicroniazide Sodum, and information about the properties of the reconstituted solution being clear and sterile.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
